Drug delivery to the back of the eye.
Kompella
U B
UB
D000998:Antiviral Agents / Q000008:administration & dosage; D052157:Aptamers, Nucleotide / Q000008:administration & dosage; D017326:Clinical Trials, Phase III as Topic; D004333:Drug Administration Routes; D016503:Drug Delivery Systems; D005128:Eye Diseases / Q000188:drug therapy*; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D007267:Injections; D008268:Macular Degeneration / Q000188:drug therapy; D053758:Nanoparticles / Q000008:administration & dosage; D016376:Oligonucleotides, Antisense / Q000008:administration & dosage; D009883:Ophthalmic Solutions; D012164:Retinal Diseases / Q000188:drug therapy; D013873:Thionucleotides / Q000008:administration & dosage; D042461:Vascular Endothelial Growth Factor A / Q000008:administration & dosage
D000998:Antiviral Agents; D052157:Aptamers, Nucleotide; D016376:Oligonucleotides, Antisense; D009883:Ophthalmic Solutions; D013873:Thionucleotides; D042461:Vascular Endothelial Growth Factor A; C495058:pegaptanib; C091346:fomivirsen